ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA approves Trazimera (trastuzumab-qyyp), biosimilar to Herceptin
March 12, 2019FDA today approved Trazimera (trastuzumab-qyyp), a biosimilar to U.S.-licensed Herceptin (trastuzumab). -
At second time of asking, Pfizer's Trazimera joins raft of Herceptin biosimilars waiting to launch in US
March 12, 2019Pfizer announced that the FDA approved Trazimera (trastuzumab-qyyp) as a biosimilar version of Roche's Herceptin (trastuzumab) for the treatment of HER2 overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction a
Pharma Sources Insight January 2025
